Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Advanced Proteome Therapeutics Corporation (TSE:APC.H)
TSXV:APC.H
Advanced Proteome Therapeutics (APC.H) Stock Price & Analysis
0 Followers
APC.H Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week Range<C$0.01 - C$0.02
Previous CloseC$0.01
VolumeN/A
Average Volume (3M)1.00K
Market Cap
N/A
Enterprise ValueC$194.73K
Total Cash (Recent Filing)$38.70K
Total Debt (Recent Filing)$30.79K
Price to Earnings (P/E)―
Beta0.95
Next Earnings
Dec 19, 2024EPS EstimateN/A
Last Dividend Ex-Date
Mar 16, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding41,127,080
10 Day Avg. Volume0
30 Day Avg. Volume1,000
Standard Deviation0.36
R-Squared0.22
Alpha-0.16
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.09
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
37.48%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
62.52% Public Companies and
Individual Investors
APC.H FAQ
What was Advanced Proteome Therapeutics Corporation’s price range in the past 12 months?
Advanced Proteome Therapeutics Corporation lowest stock price was <C$0.01 and its highest was C$0.02 in the past 12 months.
What is Advanced Proteome Therapeutics Corporation’s market cap?
Currently, no data Available
When is Advanced Proteome Therapeutics Corporation’s upcoming earnings report date?
Advanced Proteome Therapeutics Corporation’s upcoming earnings report date is Dec 19, 2024 which is in 148 days.
How were Advanced Proteome Therapeutics Corporation’s earnings last quarter?
Currently, no data Available
Is Advanced Proteome Therapeutics Corporation overvalued?
According to Wall Street analysts Advanced Proteome Therapeutics Corporation’s price is currently same.
Does Advanced Proteome Therapeutics Corporation pay dividends?
Advanced Proteome Therapeutics Corporation pays a Notavailable dividend of <C$0.01 which represents an annual dividend yield of N/A. See more information on Advanced Proteome Therapeutics Corporation dividends here
What is Advanced Proteome Therapeutics Corporation’s EPS estimate?
Advanced Proteome Therapeutics Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Advanced Proteome Therapeutics Corporation have?
Advanced Proteome Therapeutics Corporation has 41,127,080 shares outstanding.
What happened to Advanced Proteome Therapeutics Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Advanced Proteome Therapeutics Corporation?
Currently, no hedge funds are holding shares in TSE:APC.H
---
Advanced Proteome Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Advanced Proteome Therapeutics Corporation
Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.
---
Technical Analysis
BriaCell Therapeutics
―
Innoveren Scientific
―
US Stem Cell
―
Premier Biomedical
―
---